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ABSTRACT
Objectives:
The purpose of this study was to determine the relative frequency and distribution of minor salivary gland tumors and to 
provide data with respect  to age,  sex and anatomic location. To compare these data with epidemiologic findings from 
different geographic locations.
Study Design:
The retrospective records of the Department of Oral Pathology and Microbiology, Tamil Nadu Government Dental College 
and Hospital, Chennai, south India, served as a source of material for this study. All cases of salivary gland tumors reported 
over a period of 37 years were retrieved and reviewed.
Results:
Minor salivary gland tumors accounted for 185 cases (1.52% of all oral lesions) with a steady increase in the incidence rate. 
The malignant tumors (75.1%) were predominant over the benign tumors (24.9%). The tumors were distributed over a wide 
age  range,  with  a  mean age  of  46.11±13.92  years  and  a  peak  incidence  in  the  fifth  and  sixth  decades  of  life.  Male 
predominance was observed with a male to female ratio of 1.12:1. Palate (48.6%) was the most commonly involved site. 
Pleomorphic  adenoma  (21.6%)  was  the  most  common  benign  tumor  and  the  most  common  malignant  tumor  was 
mucoepidermoid  carcinoma  (34.1%)  followed  by  adenoid  cystic  carcinoma  (15.7%)  and  polymorphous  low-grade 
adenocarcinoma (9.7%).
Conclusion:
The present study reports a higher incidence (1.52%) of minor salivary gland tumors compared to other studies, with a 
predominance  of  malignant  tumors.  Our  study observed  both  regional  and  geographic  variation  in  the  frequency and 
distribution of MSGT.
Keywords:
Minor salivary gland tumors; India; Incidence; Chennai; Cancer registry; Benign salivary gland tumors; Malignant salivary 
gland tumors.
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 INTRODUCTION
Salivary  gland  tumors  constitute  a  heterogeneous  group  of  lesions  with 
varying histomorphologic features. They are uncommon constituting about 3% of all 
neoplasms.1 Approximately 80% of salivary gland tumors are found in the parotid 
gland, 10 to 15% in the submandibular gland and 5 to 10% in minor salivary glands.2 
The  annual  incidence  of  salivary  gland  tumors  varies  around  the  world  from 
approximately 0.4 to 13.5 cases per 100,000 people.3
Salivary glands are divided into major and minor salivary glands according to 
their  size.  Three  pairs  of  major  salivary  glands  –  parotid,  submandibular  and 
sublingual glands are located extra orally and their secretions reach the oral cavity 
through their ductal systems. About 600 to 1000 minor salivary glands are located 
throughout  the  oral  cavity except  in  gingiva  and anterior  part  of  the  hard  palate. 
Labial, lingual, palatal, buccal, glosso palatine and retromolar glands are located in 
the sub mucosal layer as discrete aggregates with short ducts opening directly onto the 
mucosal surface.4 About 450 minor salivary glands are found in the hard palate, 220 
in soft palate and 8 in uvula.5
According to the data provided by Armed Forces Institute of Pathology, minor 
salivary gland tumors account for about one fourth of all salivary gland tumors.3 The 
relative frequency and distribution of these tumors shows variation in several studies 
from different parts of the world. 
The global incidence of salivary gland tumors can be ascertained based on the 
documented literature.1-3, 7-15, 17-49 On the other hand, the overall incidence of salivary 
gland tumors among Indian population can be ascertained from cancer registries7,  8 
across the country and few published hospital based studies.2,  9-15 Cancer registry of 
India dates back to 1963 and is one of the oldest tumor registries of Asia6. Two types 
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of cancer registry are available in India - population based cancer registry (PBCR) 
and hospital based cancer registry (HBCR). Population based cancer registry collects 
data actively from all the healthcare facilities including pathology reports, medical 
records, radiology and radiotherapy departments and through death certificates  in a 
defined  geographical  area  providing  data  on  cancer  cases  confined  to  that  area, 
whereas hospital based cancer registry collects data passively on all cancer patients 
attending a particular hospital as per standardized proforma and such data from all the 
healthcare  centers  in  a  defined  geographical  area  results  in  pooling  of  data  for 
population based cancer registry.7 Generally, the rate of incidence of cancer cases is 
assessed based on the data provided by these registries, though the geographical area 
and population covered by these registries are small as compared to the large area and 
population of India.
Under the national cancer registry programme (NCRP), the Indian council of 
medical  research commenced a  network of cancer  registries across the country in 
December 1981. The reports of NCRP become the standard work of reference both 
within the country and abroad as well.7 A consolidated report of the population based 
cancer  registries  for  the  year  2001-  2004 was  published  by the  NCRP, ICMR in 
December 2006 with regard to the incidence and distribution of cancer cases. This 
report  covers  the  data  of  six  population  based  cancer  registries  which  includes 
Bangalore, Bhopal, Chennai, Delhi, Mumbai and Barshi for the year 2001-2003 and 
Ahmedabad PBCR for the year 2004.7 Coding of diseases in these registries is done 
according to the international classification of diseases (WHO, ICD-10) to facilitate 
comparison  of  data  from registries  across  the  world.  Salivary  gland  tumors  were 
coded as ICD-10 C07-8 and only malignant tumors of salivary glands were registered 
in these cancer registries.7
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Although  the  geographical  area  and  population  covered  by  these  cancer 
registries is limited, they give an approximate frequency of salivary gland tumors. The 
population based cancer registry at Bangalore, covers an area of 365.7 sq kms and an 
estimated urban population of  6.2 millions  as on 2003. The incidence of salivary 
gland  tumors  registered  during  2001-2003  was  45  in  males  and  22  in  females 
accounting for 0.74% and 0.3% respectively.7 Similarly, the rural cancer registry at 
Barshi covers a total population of about 0.4 million in 346 villages spread over an 
area  of  3713  sq  km.  The  incidence  of  salivary  gland  tumors  stated  for  the  year 
2001-2003 was about 5 cases in males accounting for 1.58% with none in females, 
showing exclusive predilection for males than compared to other registries.7
The Bhopal cancer registry covers a total area of 286 sq km with a population 
of  about  4.6 million and the incidence of salivary gland tumors registered during 
2001-2003  was  6  in  males  and  3  in  females,  accounting  for  0.38%  and  0.21% 
respectively.7 On the other hand, population based cancer registry of Delhi covers an 
urban area of 891.09 sq km with an estimated population of about 13.6 millions. The 
incidence of salivary gland tumors was about 124 males and 86 females accounting 
for 0.77% and 0.56% respectively, during the same period.7
The  Bombay  cancer  registry  covers  a  population  of  about  11.9  million 
occupying an area of 603 sq km. The incidence of salivary gland tumors stated for 
2001-2003 was about 81 in males and 58 in females which accounted for 0.59% and 
0.42% respectively.7 Likewise,  the  incidence  of  salivary gland tumors  reported  in 
2004 was 2 in males and 2 in females with 0.48% and 0.76% respectively, according 
to the rural cancer registry of Ahmedabad district covering an area of 7677 sq km 
with a population of 1.56 million people.7
The Madras metropolitan tumour registry (MMTR) of Chennai caters to an 
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area of 170 sq km with a population of about 4.3 million as on March 2001. The 
completeness of registration of cancer cases in MMTR is estimated to be 96%. The 
incidence of salivary gland tumors registered during 2001-2003 was 0.55% in males 
and 0.37% in females.7 In a more recent report published by MMTR, the incidence of 
salivary gland tumors has increased to 0.63% in males and 0.45% in females during 
the year 2003-2005.8 
Other  than  the  incidence  of  salivary gland  tumors  provided  by the  cancer 
registries,  there  has  been  only few recorded analysis  of  salivary gland tumors  on 
Indian  population.  Four  hospital  based  retrospective  studies  were  conducted  and 
published from southern part  of India.9,  10,  11,  12 Likewise, four more hospital based 
retrospective  studies  were  also  conducted  and  published  from  northern2,  13 and 
southwestern part of India.14,  15 These studies have either combined both major and 
minor  salivary  gland  tumors  or  was  based  only  on  the  malignant  salivary  gland 
tumors. 2, 9-13, 15  The salivary gland data from the cancer registries are concerned only 
with  the  cancer  positive  cases  and  not  inclusive  of  all  salivary  gland  tumors.7,  8 
Therefore  it  would  be  prudent  to  obtain  data  on  the  relative  frequency of  minor 
salivary tumors from the oral pathology biopsy register of institutions that caters to 
the dental needs of large population. 
Although there are approximately 10 dental teaching hospitals in Chennai, the 
Tamil Nadu Government Dental College and Hospital under the Ministry of Health 
and Family welfare, Government of Tamil Nadu is the only and the oldest tertiary 
referral  center for dental  health.  It  caters  to the dental  needs of the population of 
Chennai which is located on the southeast coast of India with an estimated population 
of 7.5 million as on 200716 as well as from other parts of Tamil Nadu and border areas 
of Andhra Pradesh. It may be noted that this was formerly known as Dental Wing of 
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Madras  Medical  College  and  Government  General  Hospital.  The  Dental  Wing 
became a separate college to be re-christened as Madras Dental College and then as 
Tamil Nadu Government Dental College and Hospital.
Studies  conducted  on a  large  number  of  cases  from a  single  source  using 
current  classification  and  accepted  diagnostic  criteria  will  help  to  determine  the 
appropriate  relative  frequency  of  minor  salivary  gland  tumors.  Therefore,  it  was 
decided  to  retrieve  all  cases  that  were  coded  as  salivary  gland  tumors  from the 
histopathology register of the Department of Oral Pathology and Microbiology, Tamil 
Nadu Government Dental College and Hospital, Chennai – 600003, South India. The 
institution based study not only provides details of patients information and diagnosis 
but also provides opportunity to re-assess the histopathological diagnosis compared to 
population based cancer registries, which provides information obtained from various 
sources with a greater chance of repetition of cases and a possibility of over diagnosis 
or under diagnosis.
The  purpose  of  this  study  is  to  determine  the  relative  frequency  and 
distribution of both the benign and malignant tumors of minor salivary gland origin 
and to provide data with reference to age, sex, site and histologic subtypes of these 
lesions from 1971 to 2008 and to compare these data with epidemiologic findings 
from different geographic locations.
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         AIMS AND OBJECTIVES
1. To determine the relative frequency and distribution of benign and malignant 
tumors of minor salivary gland origin.
2. To provide data with reference to age, sex, anatomic location and histologic 
subtypes of these lesions reported in the Department of Oral Pathology and 
Microbiology,  Tamil  Nadu  Government  Dental  College  and  Hospital, 
Chennai, South India from 1971 to 2008.





Fine et al in 196017 conducted a clinical and morphological study on 79 cases 
of minor salivary gland tumors for a period of 43 years (1916 to 1959). The benign 
tumors were about 42 (53.2%) cases with 25 (31.6%) cases of pleomorphic adenoma, 
10 (12.6%) cases of adenomas and 7 (9%) cases of myoepithelial adenoma. There 
were 37 (46.8%) malignant  neoplasms with 20 (25.2%) cases  of  mucoepidermoid 
carcinomas,  13  (16.4%)  cases  of  adenoid  cystic  carcinoma,  1(1.3%)  case  of 
adenocarcinoma, mucous carcinoma, acinus cell  carcinoma and unclassified lesion 
each. The benign tumors were predominant over malignant tumors in their study.
Wallace et al in 196318 studied 14 salivary gland tumors that occurred over a 
period of 9 years in Canadian Eskimos. Only 3 (21.4%) of them were benign mixed 
tumors and 11 (78.6%) were malignant which constituted 28% of all cancer cases. 
Among the malignant tumors, 1(7.1%) was adenoid cystic carcinoma and malignant 
papillary cystadenoma lymphomatosum each and  9  (64.3%) were  undifferentiated 
carcinomas.
Davies  et  al  in  196419 analyzed  a  series  of  129  salivary  gland  tumors  in 
Uganda Africans. Almost 25 cases (19.4%) were reported in palate and 8 in other 
minor salivary glands (6.2%). There were 19 (14.7%) cases of pleomorphic adenoma, 
1  (0.78%)  case  of  malignant  mixed  tumor,  2  (1.5%)  cases  of  mucoepidermoid 
carcinoma and anaplastic carcinoma each, 4 (3.1%) cases of adenoid cystic carcinoma 
and 5 (3.9%) cases of adenocarcinoma.
Potdar et al in 196914 analyzed the clinical behavior and management of 110 
cases of minor salivary gland tumors in Bombay, India over a period of 25 years 
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(1941-1965). About 110 cases of minor salivary gland tumors were recorded which 
constituted about 31% of all salivary gland tumors. Benign tumors were 49% and 
consisted entirely of pleomorphic adenoma, while malignant tumors accounted for 
51%. Adenoid cystic carcinoma was the most common malignant tumor with 41 cases 
(37.4%) followed by 7 cases (6.4%) of mucoepidermoid carcinoma, 4 cases (3.6%) 
each of malignant mixed tumor and adenocarcinoma.
Dhawan et al in 197020 conducted a study on central salivary gland tumors at 
All  India institute of medical sciences, New Delhi, India over a period of 6 years 
(1962-1968). Nine cases were reported with 5 cases in maxilla and 4 in mandible. 
Adenoid cystic carcinoma was the most common tumor with 4 cases followed by 3 
cases of mucoepidermoid carcinoma and 2 cases of adenocarcinoma. 
Eneroth et al in 197121 reviewed and reclassified 2,867 salivary gland tumors 
in the parotid gland, submandibular gland and the palate region for a period of 50 
years (1919 to 1969). A total of 2,513 cases were classified as salivary gland tumors. 
Of these,  185 cases  were found in  palate  with 98 cases of  pleomorphic adenoma 
(53%) and 87 cases of malignant tumors (47%) which included 44 adenoid cystic 
carcinoma  (24%),  30  mucoepidermoid  carcinoma  (16%),  3  (1.6%)  carcinoma  ex 
pleomorphic adenoma, 2 (1.08%) acinic cell carcinoma, 7 (3.8%) mucus-producing 
adenopapillary carcinoma and 1 (0.54%) solid undifferentiated carcinoma.
Spiro  et  al  in  197322 analyzed  492  cases  of  minor  salivary  gland  tumors 
clinicopathologically for a period of 25 years (1939 to 1963). Benign tumors were 
about 58 cases (11.8%) with 57 cases of pleomorphic adenoma (11.6%) and a single 
case (0.2%) of oncocytoma. Malignant tumors were most common and accounted for 
88.2% (434 cases). Among them, adenoid cystic carcinoma was the most common 
tumor  with  174  cases  (35.4%),  followed  by  106  cases  of  solid  duct  carcinoma 
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(21.5%),  76  cases  of  mucoepidermoid  carcinoma  (15.5%),  16  cases  of  mucus 
adenocarcinoma (3.3%), 14 cases of oat cell carcinoma (2.9%), 13 cases of malignant 
mixed tumor (2.6%), 12 cases of colonic-type carcinoma (2.4%), 7 cases of papillary-
cystic carcinoma (1.4%), 5 cases of clear  cell  adenocarcinoma (1.0%), 2 cases of 
papillary adenocarcinoma (0.4%),  1  case  of  spindle  cell  carcinoma (0.2%) and  6 
unclassified tumors (1.2%).
Thomas et al in 198023 studied 190 cases of salivary gland tumors in Malawi 
over a period of nine years (1969 to 1977). In this study, minor salivary gland tumors 
constituted about 49 cases (25.7%) with 32 (65.3%) cases of pleomorphic adenoma, 2 
(4.1%)  cases  of  carcinoma  in  pleomorphic  adenoma,  6  (12.2%)  cases  of 
undifferentiated carcinoma and adenoid cystic carcinoma each,  2 (4.08%) cases of 
mucoepidermoid carcinoma and 1(2.04%) case  of  hemangioma.  The crude  annual 
incidence of salivary gland tumors in this population was 0.43 per 100,000.
Isaacson et al in 198324 reported 201 cases of minor salivary gland tumors 
with 145 (72.5%) benign and 56 (27.5%) malignant tumors over a period of 21 years 
(1958 to  1979).  Pleomorphic  adenoma was  the  most  common benign  tumor  with 
69.6% followed by 2.4% of monomorphic adenoma. Among the malignant tumors, 
adenoid cystic carcinoma (10.4%) was most common followed by adenocarcinomas 
(7.4%),  mucoepidermoid  carcinoma  (6.4%),  carcinoma  in  pleomorphic  adenoma 
(2.4%) and epidermoid carcinoma (0.9%)..
Chaudhary et al in 198425 conducted a clinico-pathologic and histogenetic 
study of 189 intraoral minor salivary gland tumors over a period of 18 years (1964 to 
1982). 101 cases (53.4%) were diagnosed as benign tumors and 88 cases (46.6%) as 
malignant tumors. Pleomorphic adenoma was the most common benign tumor with 
92 cases (48.7%) followed by 4 cases (2.1%) of monomorphic adeneoma and a single 
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case (0.5%) of oncocytoma. Of 88 malignant tumors, mucoepidermoid carcinoma was 
the most common tumor with 64 cases (33.9%) as compared to 19 (10%) cases of 
adenoid  cystic  carcinoma.  4  cases  (2.1%)  were  diagnosed  as  carcinoma  ex 
pleomorphic adenoma and 1 case (0.5%) as secondary acinic cell carcinoma.
Eveson  et  al  in  198526 conducted  a  demographic  study on  2410  cases  of 
primary epithelial salivary gland tumors. A total of 336 minor salivary gland tumors 
were recorded which accounted for 14% of salivary gland tumors. The benign tumors 
comprised 53.6%, with pleomorphic adenoma being 42.6% and 11% of monomorphic 
adenoma. The malignant salivary gland tumors comprised 46.4%, with adenoid cystic 
carcinoma (13.1%) being the most common followed by adenocarcinoma (11.9%), 
mucoepidermoid  carcinoma  (8.9%),  carcinoma  in  situ  (7.1%),  undifferentiated 
carcinoma (2.1%), acinic cell carcinoma (1.8%) and squamous cell carcinoma (1.2%). 
Regezi et al in 198527 conducted a histologic and immunohistochemical study 
over a period of 19 years (1964 to 1983). A total  of 238 (0.33%) cases of minor 
salivary gland tumors were retrieved from 72,282 oral lesions. The incidence of minor 
salivary gland tumors in their study was 0.3%. Of the 150 (63.03%) benign tumors, 
119 (50%) were pleomorphic adenoma, 30 (12.60%) monomorphic adenomas which 
included 23(9.66%) cases of canalicular adenoma, 2 (0.84%) cases of oncocytoma 
and sialadenoma papilliferum each and 4 (1.68%) cases of inverted ductal papillomas. 
Out  of  88  (36.97%)  malignant  tumors,  55  (23.11%)  were  mucoepidermoid 
carcinomas,  30  (12.60%)  adenoid  cystic  carcinoma,  one  (0.42%)  epithelial-
myoepithelial carcinoma and 2 (0.84%) cases of adenocarcinoma NOS.
Chau et al in 198628 conducted a retrospective study on 98 cases of intraoral 
minor  salivary gland neoplasms  over  a  period  of  16  years  (1968 to  1984).  They 
observed  61  cases  of  benign  tumors  (62%),  out  of  which  53  (54.08%)  were 
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pleomorphic adenomas and 8 (8.16%) monomorphic adenomas. Of the 37 malignant 
tumors (38%), 19 (19.4%) were mucoepidermoid carcinomas, 12 (12.24%) adenoid 
cystic  carcinomas,  4  (4.08%)  adenocarcinomas  and  a  single  case  (1.02%)  of 
carcinoma ex pleomorphic adenoma and epidermoid carcinoma each. 
Waldron et al in 198829 conducted a demographic and histologic study on 
426 minor salivary gland tumors. Benign tumors accounted for 57.5% and malignant 
tumors  were  42.5% in  their  series.  Pleomorphic  adenoma was  the  most  common 
neoplasm with 174 cases  (40.8%) followed by 46 cases (10.7%) of monomorphic 
adenomas  which  included  26  cases  (6.1%)  of  canalicular  adenoma  and  13  cases 
(4.6%) of basal cell adenoma, 20 cases (4.6%) of cystadenomas and 5 cases (1.1%) of 
sialadenoma  papilliferum.  Mucoepidermoid  carcinoma  was  the  most  common 
malignant tumor with 65 cases (15.2%) which was followed by 47 cases (11%) of 
polymorphous  low-grade  adenocarcinoma,  40  cases  (9.3%)  of  adenoid  cystic 
carcinoma, 15 cases (3.5%) of acinic cell carcinoma, 6 cases (1.6%) of carcinoma ex 
pleomorphic adenoma, 2 cases (0.6%) of clear cell carcinoma and 6 cases (1.6%) of 
adenocarcinoma.
Takahashi et al in 199030 conducted a demographic and histologic study of 
200 cases of intraoral minor salivary gland tumors. Benign tumors accounted for 127 
cases (63.5%) with 124 cases (62%) of pleomorphic adenomas and 3 cases (1.5%) of 
monomorphic  adenomas  which  included 2 (1%) cases  of  basal  cell  adenoma and 
1(0.5%) case of oncocytoma.  The malignant tumors were about  73 cases (36.5%) 
represented  by 33  (16.5%) adenoid  cystic  carcinoma,  16  (8.0%) mucoepidermoid 
carcinoma,  10  (5%)  carcinoma  ex  pleomorphic  adenoma,  6  (3%)  acinic  cell 
carcinoma, 5 (2.5%) adenocarcinomas and a single cases of (0.5%) polymorphous 
low-grade adenocarcinoma, undifferentiated carcinoma and clear cell carcinoma each.
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Van Heerden et  al  in  199131 studied retrospectively 70 cases  of  intraoral 
minor salivary gland neoplasms in an African population for a period of 8 years. Out 
of which, 34 cases (48%) were classified as benign and 36 cases (52%) as malignant 
tumors. All the benign tumors were pleomorphic adenoma, while polymorphous low-
grade adenocaracinoma was the most common malignant tumor with 11 cases which 
accounted  for  15.7% of  MSGT.  Adenoid  cystic  carcinoma  was  the  second  most 
common  malignant  tumor  with  9  cases  (12.8%)  followed  by  mucoepidermoid 
carcinoma with 6 cases  (8.6%),  carcinoma ex pleomorphic adenoma with 5 cases 
(7.1%),  adenocarcinoma  NOS  with  3  cases  (4.2%)  and  a  single  case  (1.4%)  of 
epithelial-myoepithelial carcinoma and undifferentiated carcinoma each.
Rippin et al in 199232 studied 194 cases of intra-oral salivary gland tumors in 
United Kingdom for a period of 13 years (1975 to 1988). Benign tumors were 106 
cases (55%) whereas 88 cases (45%) were malignant. Pleomorphic adenoma was the 
most common benign tumor with 77 cases (40%). This was followed by 21 cases 
(11%)  of  monomorphic  adenoma,  4  cases  (2%)  of  oncocytoma  and  papillary 
cystadenoma each. Adenoid cystic carcinoma was the most common malignant tumor 
with 37 cases (19%) followed by 33 cases (17%) of mucoepidermoid carcinoma, 16 
cases (8%) of adenocarcinoma and 2 cases (1%) of undifferentiated carcinoma.
Van der wal et  al  in 199233 reclassified 101 minor  salivary gland tumors 
histologically over a period of 18 years (1970 to 1988). Benign tumors were 42 cases 
(42%) and the remaining 59 cases (58%) were malignant. Pleomorphic adenoma was 
the most common benign tumor with 33 cases (33%) followed by 4 cases (4%) of 
myoepithelioma, 3 cases (3%) of canalicular adenoma and 1 case (1%) of basal cell 
adenoma  and  intraductal  papilloma  each.  Among  the  malignant  tumors,  adenoid 
cystic carcinoma was the most common tumor with 27 cases (26%) followed by 13 
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cases (13%) of mucoepidermoid carcinoma, 8 cases (8%) of polymorphous low-grade 
adenocarcinoma,  4  cases  (4%)  of  acinic  cell  carcinoma,  3  cases  (3%)  of 
adenocarcinoma NOS, 2 cases (2%) of carcinoma ex pleomorphic adenoma and 1 
case (1%) of papillary cystadenocarcinoma and salivary duct cyst each.
Loyola et al  in  199534 conducted a  retrospective analysis  on 164 cases of 
minor salivary gland tumors over a period of 23 years (1970 to 1993). Benign tumors 
accounted for 62% whereas malignant tumors were about 38%. Pleomorphic adenoma 
was the most common benign tumor which accounted for 53%, followed by 4% of 
cystadenoma, 2% of myoepithelioma and 1% of inverted ductal papilloma, basal cell 
adenoma  and  intraductal  papilloma  each.  Among  the  malignant  tumors, 
mucoepidermoid carcinoma was the most common tumor with 17% followed by 13% 
adenoid cystic carcinoma,  4% acinic cell  carcinoma,  2% polymorphous low-grade 
carcinoma and 1% of epithelial myoepithelial carcinoma and adenocarcinoma each.
Rivera-Bastidas et al in 19961 performed a retrospective analysis on 62 cases 
of intraoral minor salivary gland tumors in Venezuelan population over a period of 24 
years (1968 to 1992). Out of 9,000 cases, minor salivary gland tumors were about 62 
cases (0.7%), with 34 cases (55%) being benign and 28 cases (45%) malignant. The 
incidence of MSGT in their study was 0.7%. Of the benign tumors, 24 (38.71%) were 
pleomorphic adenoma, 4 (6.45%) cystadenoma, 3 (4.84%) sialadenoma papilliferum, 
2  (3.22%)  basal  cell  adenoma  and  1  case  (1.61%)  of  inverted  ductal  papilloma. 
Among  28  malignant  tumors,  18  (29.03%)  were  mucoepidermoid  carcinoma,  6 
(9.68%)  adenoid  cystic  carcinoma  and  2  cases  (3.22%)  of  adenocarcinoma  and 
undifferentiated carcinoma each.
Lopes et  al  in  199935 retrospectively studied 196 cases  of  intraoral  minor 
salivary gland tumors from a pool of 40,000 head and neck lesions for a period of 39 
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years (1954 to 1993). The incidence of MSGT in their study was 0.4%. Out of 196 
cases, 68 cases were benign and 128 malignant showing a predominance of malignant 
(65.3%) over  benign (34.7%) tumors.  Pleomorphic adenoma was the predominant 
benign  tumor  with 65 (33.16%) cases,  followed by 3 (1.53%) cases  of  basal  cell 
adenoma. The most common malignant tumor was mucoepidermoid carcinoma with 
76 cases (38.78%), followed by 34 cases (17.35%) of adenoid cystic carcinoma, 9 
cases (4.6%) of adenocarcinoma NOS, 3 cases (1.53%) of polymorphous low-grade 
adenocarcinoma,  2  (1.02%)  cases  of  salivary  duct  carcinoma  and  papillary 
cystadenocarcinoma each and 1 (0.51%) case of acinic cell carcinoma and basal cell 
adenocarcinoma each.
Sousa et al in 200115 analyzed 62 cases of salivary gland tumors at a tertiary 
referral center in Goa, India over a period of 10 years (1987-1997). Minor salivary 
gland tumors were 3 cases (4.8%) with 2 cases of pleomorphic adenoma and 1 case of 
adenoid cystic carcinoma.
Ahmad et al in 200213 conducted a clinico-pathological study on 100 primary 
salivary gland tumors in Kashmir,  India over a period of 2 years (1998 to 2000). 
Minor salivary gland tumors constituted about 12% with 66.6% benign and 33.4% 
malignant tumors. Pleomorphic adenoma was the most common benign tumor with 
58.3% followed by 8.3% of myoepithelioma. Among the malignant tumors, adenoid 
cystic carcinoma was most common and accounted for 25% of minor salivary gland 
tumors followed by 8.4% of adenocarcinoma.
Jansisyanont et al in 200236 reported their experience on 80 cases of intraoral 
minor  salivary  gland  tumors  reported  over  a  period  of  10  years  (1991  to  2001). 
Malignant tumors were predominant with 61 cases (76.3%) compared to 19 cases of 
benign tumors (23.7%). Pleomorphic adenoma was the most common benign tumor 
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with 17 cases (21.3%), followed by a single (1.25%) case of basal cell adenoma and 
canalicular adenoma each. Likewise, mucoepidermoid carcinoma was most common 
with 33 cases (41.3%), followed by 7 cases (8.8%) of adenoid cystic carcinoma, 3 
cases (3.8%) of adenocarcinoma  and acinic cell carcinoma each, 9 cases (11.3%) of 
polymorphous  low-grade  adenocarcinoma  and  6  cases  (7.5%)  of  undifferentiated 
carcinoma.
Vargas  et  al  in  200237 retrospectively  studied  salivary  gland  tumors  in 
brazilian population for a period of 7 years (1993 to 1999). A total of 124 patients 
with 99 benign (80%) and 25 malignant (20%) tumors were diagnosed. Only 6 tumors 
(5%) were reported in minor salivary glands.  Pleomorphic adenoma was the most 
common benign neoplasm with 2 cases being reported in minor salivary glands. A 
total of 4 malignant tumors were diagnosed in minor salivary glands with 3 cases of 
mucoepidermoid carcinoma and one case of adenoid cystic carcinoma.
Pandey et al in 20039 analyzed 42 cases of malignant minor salivary gland 
tumors for a period of 17 years (1982 to 1999). Mucoepidermoid carcinoma was the 
most common tumor with 19 cases (45.2%), followed by 9 cases (21.4%) of adenoid 
cystic  carcinoma,  7  cases  (16.6%) of  adenocarcinoma,  5  cases  (11.9%) of  mucin 
producing adenocarcinoma and 2 cases (4.8%) of undifferentiated carcinoma.
Sajeevan et al in 200310 analyzed 30 cases of salivary gland lesions over a 
period of 9 years (1993 to 2001). Minor salivary gland tumors accounted for 16.6% 
occurring predominantly in palate. 50% were diagnosed as pleomorphic adenoma and 
50% as mucoepidermoid carcinoma.
Dorairajan et al in 200411 conducted a retrospective study on salivary gland 
tumors  at  Madras  Medical  College  and  Research  institute,  Government  General 
Hospital, Chennai for a period of 10 years (1991-2001). A total of 436 salivary gland 
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tumors were diagnosed, with a male to female ratio of 3.3:1. Minor salivary gland 
tumors were about 27 cases (6%) with 8 cases being benign and the remaining 19 
cases  were  malignant  tumors.  Adenoid  cystic  carcinoma  was  the  most  common 
malignant tumor with 9 cases (33.3%) followed by 7 cases (26%) of adenocarcinoma 
and 3 cases (11.1%) of mucoepidermoid carcinoma.
Hyam et al  in  200438 studied retrospectively 30 cases of malignant  minor 
salivary  gland  tumors  over  a  period  of  22  years  (1980 to  2002).  Adenoid  cystic 
carcinoma  was  most  common  with  12  cases  (40%)  followed  by  9  cases  of 
mucoepidermoid  carcinoma  (30%),  6  cases  (20%)  of  polymorphous  low  grade 
adenocarcinoma,  2  cases  (7%)  of  adenocarcinoma  and  a  single  case  (3%)  of 
malignant salivary gland tumor of uncertain malignancy.
Kasangaki et al in 200439 studied retrospectively 142 cases of salivary gland 
tumors  in  Uganda  population  over  a  period  of  12  years  (1988  to  2000).  These 
constituted  about  7.5%  of  all  oral  neoplasms.  Almost,  54.23%  of  cases  were 
diagnosed as benign and 45.77% as malignant. Pleomorphic adenoma was the most 
common benign  tumor  and accounted  for  77.9% followed by 18.18% of  salivary 
gland  adenoma  and  3.9%  of  oncocytoma.  Among  the  malignant  salivary  gland 
tumors,  adenocarcinoma was most prevalent with 36.92%, followed by 27.69% of 
adenoid cystic carcinoma, 9.23% of mucoepidermoid carcinoma, 6.15% of mucous 
secreting  carcinoma,  4.62% of  acinic  cell  carcinoma and 3.08% of  carcinoma ex 
pleomorphic adenoma.
Nagarkar NM et al in 20042 conducted a retrospective study on 36 salivary 
gland tumors in Government Medical College and Hospital, Chandigarh over a period 
of 4 years (1997 to 2001). Minor salivary gland tumors constituted about 25%, with 
66.6% benign  and  33.4% malignant  tumors.  Pleomorphic  adenoma  was  the  most 
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common tumor  which  accounted  for  66.6% of  all  tumors,  followed by 22.2% of 
adenoid cystic carcinoma and 11.1% of mucoepidermoid carcinoma.
Vuhahula in 200440 conducted a clinicopathological study on salivary gland 
tumors in Uganda over a period of 10 years (1979 to 1988). A total of 268 cases of 
salivary gland tumors were diagnosed, out of which 145 (54%) were benign and 123 
malignant (46%) with a malignant to benign ratio of 1:1.18. Minor salivary gland 
tumors accounted for 88 cases (32.8%), with 41 benign (46.9%) and 47 malignant 
tumors (53.4%). Of the 41 benign minor salivary gland tumors, 28 were pleomorphic 
adenoma  (68.3%),  8  myoepithelioma  (19.5%),  1  basal  cell  adenoma  (2.4%),  1 
oncocytoma  (2.4%)  and  3  cystadenoma  (7.4%).  Among  the  47  malignant  minor 
salivary gland tumors, adenoid cystic carcinoma was most common with 18 cases 
(38.3%), followed by 9 cases (19.2%) of mucoepidermoid carcinoma, 5 cases (10.6%) 
of acinic cell carcinoma, 2 cases (4.3%) of epithelial-myoepithelial carcinoma, 7 cases 
(14.9%)  of  polymorphous  low-grade  adenocarcinoma,  3  cases  (6.4%)  of 
adenocarcinoma, 2 cases (4.3%) of carcinoma in pleomorphic adenoma and 1 cases 
(2.1%) of malignant myoepithelioma.
Lima et al in 200541 conducted an epidemiological survey on salivary gland 
tumors over a period of 19 years (1980 to 1999). A total of 245 cases were reported 
which accounted for 0.15% of the all cases. Minor salivary gland tumors were about 
46  cases  (18.78%),  with  24  (52.17%)  benign  tumors  and 22  (47.83%) malignant 
tumors. Pleomorphic adenoma was the most common benign tumor with 23 (50%) 
cases,  followed  by  a  single  (2.17%)  case  of  canalicular  adenoma.  Among  the 
malignant minor salivary gland tumors, adenoid cystic carcinoma was most common 
with  about  8  cases  (17.4%),  followed  by  6  (13.04%)  cases  of  mucoepidermoid 
carcinoma,  3(6.52%)  cases  of  acinic  cell  carcinoma,  4  (8.7%)  cases  of 
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adenocarcinoma and 1 (2.17%) case of carcinoma in pleomorphic adenoma.
Toida  et  al  in  200542 retrospectively  studied  82  cases  of  intraoral  minor 
salivary gland tumors over a period of 24 years (1979 to 2003). Out of these, 55 cases 
(67.1%)  were  benign  tumors  and  27  cases  (32.9%)  were  malignant.  The  benign 
tumors consisted of 54 (65.85%) cases of pleomorphic adenoma and a single case 
(1.22%)  of  papillary  cystadenoma.  Among  the  malignant  tumors,  adenoid  cystic 
carcinoma was most common with 10 cases (12.2%), followed by 8 cases (9.76%) of 
mucoepidermoid  carcinoma,  3  cases  (3.66%)  of  acinic  cell  carcinoma,  2  cases 
(2.44%)  of  adenocarcinoma  and  carcinoma  in  pleomorphic  adenoma  each,  1case 
(1.22%) of basal cell adenocarcinoma and papillary cystadenocarcinoma each.
Yih  et  al  in  200543 reviewed  213  cases  of  intraoral  minor  salivary  gland 
neoplasms over a period of 37 years (1964 to 2001) and observed 119 benign tumors 
(56%) and 94 malignant tumors (44%). Pleomorphic adenoma was the most common 
benign tumor with 93 cases (43.66%), followed by 25 (11.74%) cases of canalicular 
adenoma and a single (0.47%) case of oncocytoma. The most common malignant 
neoplasm was mucoepidermoid carcinoma which represented 45 (21.13%) cases out 
of 94 malignant lesions.  Adenoid cystic  carcinoma was the second most  common 
neoplasm with 22 (10.33%) cases followed by 18 cases (8.45%) of polymorphous 
low-grade  adenocarcinoma,  4  cases  (1.88%)  of  adenocarcinoma  NOS,  2  cases 
(0.94%)  of  carcinoma  ex  pleomorphic  adenoma,  1  case  (0.47%)  of  acinic  cell 
carcinoma, papillary cystadenocarcinoma and  cystadenocarcinoma each.
Jaber et  al  in  200644 reviewed 75 cases  of  intraoral  minor  salivary gland 
tumors in Libyan population over a period of 23 years (1977 to 2000). The frequency 
of benign tumors was 38.6% (29 cases) and 61.3% for malignant tumors (46 cases). 
Pleomorphic adenoma was the most common benign tumor with 23 cases (30.6%) 
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followed by 3 (4%) cases of cystadenoma, 2 cases (2.6%) of basal cell adenoma, and 
1  case  (1.33%) of  canalicular  adenoma.  The  most  common malignant  tumor  was 
mucoepidermoid carcinoma with 19 cases (25.3%), followed by 13 cases (17.3%) of 
adenoid  cystic  carcinoma,  8  (10.67%) cases  of  adenocarcinoma,  3  (4%) cases  of 
polymorphous  low-grade  adenocarcinoma,  2  (2.6%)  cases  of  carcinoma  ex 
pleomorphic adenoma and one (1.33%) case of epidermoid carcinoma.
Buchner et  al  in  200745 conducted  a  retrospective  study on  380 cases  of 
intraoral minor salivary glands from a pool of 92,860 cases during a period of 20 
years (1986 to 2005). The minor salivary gland tumors constituted about 0.4% with 
224  benign  tumors  (59%)  and  156  malignant  tumors  (41%).  Of  the  224  benign 
tumors,  pleomorphic  adenoma  was  the  most  common  with  149  cases  (39.2%), 
followed  by  24  cases  (6.3%)  of  cystadenoma,  23  cases  (6.1%)  of  canalicular 
adenoma, 12 cases (3.16%) of sialadenoma papilliferum, 6 cases (1.6%) of basal cell 
adenoma, 5 cases (1.3%) of myoepithelioma, 3 cases (0.8%) of intraductal papilloma 
and 2 cases (0.5%) of inverted ductal papilloma. Among the 156 malignant tumors, 83 
(21.8%)  were  mucoepidermoid  carcinoma,  27  (7.1%)  polymorphous  low-grade 
adenocarcinoma, 24 (6.3%) adenoid cystic carcinoma, 6 (1.6%) acinic cell carcinoma, 
8  (2.1%)  adenocarcinoma  NOS,  4  (1%)  clear  cell  carcinoma  NOS,  2  (0.5%) 
carcinoma  ex  pleomorphic  adenoma  and  1  cases  (0.25%)  of  basal  cell 
adenocarcinoma and myoepithelial carcinoma each.
Pires et al in 200746 conducted a clinicopathological study on 546 cases of 
intraoral minor salivary gland tumors over a period of 14 years (1991 to 2005). These 
tumors accounted for 0.4% of all  cases with 305 benign tumors (55.9%) and 241 
malignant  tumors  (44.1%).  Pleomorphic  adenoma  was  the  most  common  benign 
tumor with 181 cases (33.2%), followed by 50 cases (9.2%) of canalicular adenoma, 
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42 cases (7.7%) of papillary cystadenoma, 16 cases (2.9%) of ductal cystadenoma, 9 
cases (1.6%) of sialadenoma papilliferum, 4 cases (0.7%) of oncocytoma,  2 cases 
(0.4%) of intraductal papilloma and 1 case (0.2%) of myoepithelioma. Among the 
malignant  tumors,  mucoepidermoid  carcinoma was  most  common with  125 cases 
(22.9%) followed by 35 cases (6.4%) of adenoid cystic carcinoma, 28 cases (5.1%) of 
polymorphous  low-grade  adenocarcinoma,  21  cases  (3.8%)  of  acinic  cell 
adenocarcinoma  and  adenocarcinoma  each,  3  cases  (0.5%)  of  adenosquamous 
carcinoma,  2  cases  (0.4%)  of  carcinoma  ex-pleomorphic  adenoma  and  epithelial-
myoepithelial  carcinoma each and 1 case (0.2%) of papillary cystadenocarcinoma, 
mucinous adenocarcinoma, myoepithelial carcinoma and clear cell carcinoma each.
Wang  et  al  in  200747 conducted  a  retrospective  study on  intraoral  minor 
salivary gland tumors in Chinese population over a period of 14 years (1990 to 2004). 
A total of 737 minor salivary gland tumors consisted of 340 (46.1%) benign and 397 
(53.9%)  malignant  tumors  were  reported.  Pleomorphic  adenoma  was  the  most 
common benign neoplasm with 278 cases (37.72%), followed by 49 cases (6.64%) of 
myoepithelioma, 4 cases (0.54%) of basal cell adenoma, 1 case (0.14%) of  warthin’s 
tumor, 6 cases (0.81%) of cystadenoma and 2 cases (0.27%) of ductal papillomas. 
Adenoid cystic carcinoma was the most frequent type of malignant tumors with 143 
cases (19.40%), followed by 91 cases (12.35%) of mucoepidermoid carcinoma, 41 
cases (5.56%) of adenocarcinoma NOS, 34 cases (4.61%) of polymorphous low-grade 
adenocarcinoma, 24 cases (3.26%) of myoepithelial carcinoma, 22 cases (2.99%) of 
carcinoma ex pleomorphic adenoma, 13 cases (1.76%) of undifferentiated carcinoma, 
10  cases  (1.36%)  of  adenosquamous  carcinoma,  8  cases  (1.09%)  of 
cystadenocarcinoma, 7 cases (0.95%) of acinic cell carcinoma, 3 cases (0.41%) of 
epithelio-myoepithelial carcinoma and 1 case (0.14%) of salivary duct carcinoma.
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Copelli et al in 200848 reviewed 43 cases of malignant minor salivary gland 
tumors over a period of 9 years (1995 to 2004). Adenoid cystic carcinoma was the 
most common tumor which accounted for 60.6% followed by 27.9% mucoepidermoid 
carcinoma,  4.6%  adenocarcinoma  NOS,  2.3%  polymorphous  low-grade 
adenocarcinoma and 4.6% cases of acinic cell carcinoma. 
Jones et al in 200849 conducted a demographic study on 741 salivary gland 
tumors from a pool of 58,880 biopsy specimens over a period of 31 years (1974 to 
2005). Among this, the minor salivary gland tumors accounted for 455 cases (61.8%), 
out of which 283 cases (62.2%) were benign and 172 cases (37.8%) were malignant. 
Pleomorphic adenoma was the most common benign salivary gland tumor with 184 
cases (40.4%) of minor salivary gland tumors, followed by 35 cases (7.7%) of basal 
cell adenoma, 34 cases (7.5%) of canalicular adenoma, 11 cases (2.4%) of papillary 
cystadenoma,  7  cases  (1.5%)  of  myoepithelioma,  5  cases  (1.1%)  of  intraductal 
papilloma, 4 cases (0.9%) of sialadenoma papilliferum, 2 cases (0.4%) of inverted 
duct  papilloma  and  1  case  (0.2)  of  oncocytoma.  Among  the  malignant  tumors, 
mucoepidermoid  carcinoma  was  the  most  common  tumor  with  59  cases  (13.0%) 
followed  by  52  cases  (11.4%)  of  adenoid  cystic  carcinoma,  28  cases  (6.2%)  of 
polymorphous  low-grade  adenocarcinoma,  11  cases  (2.4%)  of  carcinoma  ex 
pleomorphic  adenoma,  6  cases  (1.3%)  each  of  acinic  cell  carcinoma  and 
adenocarcinoma NOS, 3 cases (0.7%) of basal cell adenocarcinoma, 2 cases (0.4%) 
each of papillary cystadenocarcinoma and salivary duct carcinoma and 1 case (0.1%) 
each of clear cell carcinoma, mucinous adenocarcinoma and myoepithelial carcinoma.
Subhashraj et al in 200812 analyzed 684 cases of salivary gland tumors over a 
period of 16 years (1991 to 2006). About 150 cases of minor salivary gland tumors 
were reported which accounted for 22% of all salivary gland tumors with 91 cases 
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(60.67%) of benign tumors and 59 (39.33%) cases of malignant tumors. Pleomorphic 
adenoma was most common with 87 cases (58%), followed by 2 cases (1.33%) of 
basal cell adenoma, 1 case (0.67%) of oncocytoma and unclassifiable benign tumor 
each. Among 59 cases of malignant tumors, adenoid cystic carcinoma was the most 
common malignant tumor with 25 cases (16.67%), followed by 10 cases (6.67%) of 
mucoepidermoid  carcinoma,  9  cases  (6%)  of  adenocarcinomas,  3  cases  (2%)  of 
carcinoma  ex-pleomorphic  adenoma  and  squamous  cell  carcinoma  each,  2  cases 
(1.33%) of myoepithelial carcinoma and epithelial-myoepithelial carcinoma each, 1 
case  (0.67%)  of  acinic  cell  carcinoma,  cystadenocarcinoma,  carcinosarcoma, 
lymphoepithelial  carcinoma,  basal  cell  adenocarcinoma  and  mucinous 
adenocarcinoma each.
AGE, GENDER AND ANATOMIC LOCATION
 Fine et al in 196017 conducted clinical and morphological study on 79 cases 
of minor salivary gland tumors. They observed that the average age in their patients 
ranged from 42 to 46.3 years. The average age for benign tumors was 46.3 years and 
54.4 years for malignant tumors.  There was a female predominance with a male to 
female ratio of 1:1.2. Palate was the most common location with 41 cases (51.9%) 
followed  by 12  (15.19%)  in  lips,  13  (16.46%)  in  cheeks,  1  (1.27%)  in  tonsil,  4 
(5.06%) in tongue and 8 (10.13%) in the floor of the mouth. 
Davies et al in 196419 observed that the age ranged from 15 to 64 years, with a 
peak incidence in 25 to 34 years and female predominance with a male to female ratio 
of 1:1.75, in their retrospective study on 14 salivary gland tumors.
Potdar et al in 196914 reviewed 110 cases of minor salivary gland tumors and 
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observed that the age ranged from 10 to 76 years, with a mean age of 40.8 years for 
males and 46.4 years for females. Their study showed a male predominance with a 
male to female ratio of 1.8:1. Palate was most commonly involved with 59 cases 
(53.6%) followed by 10 cases (9%) in maxillary sinus, 9 cases (8.2%) each in cheek 
and tongue, 5 cases (4.5%) in alveolus, 3 cases (2.7%) in lips, 1 case (0.9%) in floor 
of the mouth and the remaining 14 cases (12.7%) in other intraoral sites.
 Spiro et  al  in  197322 analyzed 492 cases  of  minor  salivary gland tumors 
clinicopathologically  and  found  that  the  age  ranged  from 7  to  86  years  with  an 
average age of 53 years. The median age was 48 years for benign tumors which was 
lower than 56 years observed for malignant tumors. They reported an almost equal 
frequency, with a male to female ratio of 1:1.02.  Palate was the most common site 
with 181 cases (36.8%), followed by 67 cases in maxillary antrum (13.6%), 54 in 
tongue (11.0%), 49 in cheek or lips (10.0%), 47 in nasal cavity (9.6%), 29 in gingiva 
(5.9%), 17 in floor of the mouth (3.5%), 15 in larynx (3.0%), 11 in tonsil (2.2%), 10 
in nasopharynx (2.0%), 8 in ethmoid (1.6%) and 4 in oropharynx (0.8%).
Thomas et al in 198023 studied 190 cases of salivary gland tumors in Malawi 
over a period of nine years and found that the average age for patients with benign 
tumors were 39.4 years and 40.8 years for malignant tumors. They observed an almost 
equal frequency with a male to female ratio of 1:1.18. Palatal tumors were slightly 
more common in females. Palate was most commonly involved with 36 cases (18.9%) 
and 13 cases in other minor salivary glands (6.8%).
Eveson et al in 198526 conducted a demographic study on 336 minor salivary 
gland tumors and reported that the mean age for benign salivary gland tumors was 
49.2±  18.3  and  55.9±16.3  for  malignant  tumors.  The  mean  age  for  males  was 
52.0±17.2 and 52.1±18.6 for females. The peak incidence was in the seventh decade 
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for  males  and  sixth  decade  for  females.  They observed  that  palate  was  most 
commonly involved with 54% of cases followed by 21% in lips and 11% in buccal 
mucosa and the remaining (14%) in other intraoral sites.
Regezi  et  al  in  198527 analyzed  238  minor  salivary  gland  tumors  both 
histologically and immuno histochemically. Their study revealed that palate was most 
commonly involved with 109 cases (45.8%) followed by 61 cases (25.63%) in upper 
lip, 37 (15.55%) in buccal mucosa and gingiva, 8 (3.36%) in lower lip, 6 (2.52%) in 
retromolar region, 5 (2%) in floor of the mouth and one (0.42%) case in tongue
Chau et al in 198628 conducted a retrospective study on 98 cases of intraoral 
minor salivary gland neoplasms and observed that the age range in their patients was 
13 to79 years with a mean age of 44±18.9 years, for males being 43±17.5 and females 
44±20.2. For benign neoplasms, the age ranged from13 to 79 years with a mean age 
of 42±18.9 years and the mean age for both males and females was 42 years. For 
malignant neoplasms, the age ranged from 15 to 79 years with a mean age of 45±18.8 
years and the mean age for both males and females was 45years. The age distribution 
was bimodal with the first peak in the third decade and second peak in the seventh 
decade. They reported an equal frequency with a male to female ratio of 1:1. Palate 
(61%) was most commonly affected which was followed by cheek (14%), upper lip 
(10%), retromolar region(7%), lower lip(2%), tongue (1%) and intra-bony (mandible 
2%, maxilla1%). 
Waldron et al in 198829 conducted a demographic and histologic study on 
426 minor salivary gland tumors and observed that the age range was from 8 to 100 
years. The mean age for patients with benign tumors was 49.8±19.12 years whereas 
the mean age for malignant tumors was 55.2±17.59. The mean age for patients with 
malignant tumors was 5.4 years greater than for patients with benign tumors. The 
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mean age for male patients was 50.6±17.20 and 53.1±19.48 for female patients. They 
showed an overall female predominance with a male to female ratio of 1:1.59. Palate 
(42.5%) was the most frequent site of involvement followed by upper lip (18.5%), 
buccal mucosa (15%), retromolar region (5.4%), floor of the mouth (4.8%), maxillary 
vestibule (4.3%), lower lip (3.4%) and 6.1% in other intraoral sites.
Takahashi et al in 199030 retrospectively studied 200 cases of intraoral minor 
salivary gland tumors and reported that the patient’s age ranged from 10 to 85 years. 
The mean age for patients with benign tumors was 44.8±17.3 years and 54.8±13.3 
years for malignant tumors. The peak incidence for benign tumors was in the fourth 
and fifth decades and for malignant tumors in the seventh decade. The mean age for 
female patients was 47.2±16.2 years and for male patients 50.6±17.3 years. The peak 
incidence for males was in the sixth and seventh decade and for females in the fourth, 
fifth  and sixth decades. They reported marked female predominance with male to 
female ratio of 1.8:1. Palate was most commonly involved with 132 (66%) cases in 
palate, followed by 23 (11.5%) in lip, 17 (8.5%) in buccal mucosa, 12(6%) in gingiva, 
8 (4%) in floor of mouth, 7 (3.5%) in tongue and 1 (0.5%) case in mandible
Van Heerden et  al  in  199131 studied retrospectively 70 cases  of  intraoral 
minor salivary gland neoplasms in an African population and observed the age range 
to be 10 to 85 years. The age range for benign tumors was 10 to 64 years, with a mean 
age of 36.5±14.7 years. The age range for malignant tumors was 22 to 85, with a 
mean age of 49.8±16.3. They showed female predominance with a male to female 
ratio of 1:1.6. Palate (82.8%) was most frequently involved which was followed by 
upper lip (7.1%), buccal mucosa (5.7%) and floor of the mouth, retromolar region and 
mandibular gingiva with 1.4% each.
Rippin et al in 199232 studied 194 cases of intra-oral salivary gland tumors in 
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United Kingdom and reported a mean age of 50.4 years. The mean age for males was 
50.7 years and 50.1 years for females. They observed female predilection with a male 
to female ratio of 1:1.13.  Their  study showed that 48% of all  tumors occurred in 
palate which was followed by 16% in upper lip, 15% in cheek, 12% in floor of the 
mouth and remaining in other intraoral sites.
Van der wal et al in 199233 reclassified 101 intraoral minor salivary gland 
tumors histologically and reported that the age ranged from 17 to 86 years, with a 
mean age of 53.6 years for males and 16 to 82 years, with a mean age of 50 years for 
females.  Their  study revealed an equal  frequency in  both genders with a  male  to 
female ratio 1:1. Palate was the most common location with 61 cases (60%) followed 
by 13 cases (13%) in lips, 8 cases (8%) in cheeks, 7 cases (7%) in floor of the mouth 
and upper alveolar ridge each, 3 cases (3%) in retromolar area and 1 case (1%) in 
mandible and tongue each. 
Loyola et al in 199534 observed that the patient’s age ranged from 8 to 81 
years with a mean age of 41.5±17.5 years. The mean age for males was 42.2±17.2 and 
for females 41.7±17.1 years. The age range for benign tumors was 8 to 81 with a 
mean of 39.9±18.7 years, whereas the age range for malignant tumors was 17 to 72 
years with a mean of 43.5±15.4 years suggesting that the malignant tumors occur in 
older patients compared to benign tumors. They observed female predominance with 
a male to female ratio of 1:1.3. Palate was the most commonly involved site for both 
benign and malignant tumors (67% of benign and 73% of malignant tumors) followed 
by buccal mucosa (17%) and lip (10%) for benign tumors. The other common site for 
malignant tumors was retromolar area (13%) and buccal mucosa (8%).
Rivera-Bastidas et al in 19961 studied retrospectively 62 cases of intraoral 
minor salivary gland tumors and observed that the age range of the patients was 10 
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to72 years with a peak incidence in 21-30 years. For benign tumors, the patient age 
ranged from 10 to 72 years with a mean of 38 years. The mean age for females was 39 
years and 37 years for males. The peak incidence of benign tumors occurs in 21-30 
years for males and 31-40 years for females. For malignant lesions, the age range was 
from 10 to 71 years with a mean age of 42±17.96 years. The mean age for females 
was  45  years  and  37  years  for  males.  This  suggests  that  the  peak  incidence  of 
malignant tumors occurs in 41-50 year old group for females.  They showed female 
predominance  with a  male  to  female ratio  of  1:1.8.  The male to  female ratio  for 
benign  tumors  was  1:2.4  indicating  a  higher  proportion  of  benign  tumors  among 
females, whereas the male to female ratio for malignant tumors was 1.4:1 indicating 
male predominance. Palate (54.8%) was most commonly involved followed by lips 
(12.9%),  cheeks  (9.7%),  floor  of  the  mouth  (8.1%),  retromolar  region  (6.5%), 
mandible (1.6%), maxilla (1.6%) and site not specified in 4.8%. 
Lopes  et  al  in  199935 retrospectively studied 196 cases  of  intraoral  minor 
salivary gland tumors and observed that the mean age for benign tumors was 43.5 
years and 49.1 years for malignant tumors. They reported an equal frequency in both 
males and females with a male to female ratio of 1:1. The ratio for benign tumors was 
1:1.3, showing a predominance of benign tumors in females and 1.16:1 for malignant 
tumors  with  predominance  of  malignant  tumors  in  males. Palate  was  commonly 
involved with 138 cases (70.4%) followed by 19 cases (9.7%) in tongue, 13(6.63%) in 
buccal mucosa, 12 (6.12) in retromolar region, 10 (5.1%) in lip, 9 (4.6%) in alveolar 
mucosa and 5 (2.5%) cases in floor of the mouth.
Ahmad et al in 200213 conducted a clinico-pathological study on 100 primary 
salivary gland tumors in Kashmir, India over a period of 2 years and reported palatal 
predominance accounting for 58.3% followed 16.6% in nasal region and 8.3% each in 
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lip, cheek and parapharyngeal space.
Jansisyanont et al in 200236 reported their experience on 80 cases of intraoral 
minor salivary gland tumors reported over a period of 10 years and observed that the 
median age for minor salivary gland tumors was 54 years for males and 55 years for 
females. The patients age ranged from 9 to 84 years for malignant tumors and 33 to 
90 years for benign tumors. The median age for benign tumors was 64.5 years for 
males and 58 years for females. The median age for malignant tumors was 52 years 
for males  and 54 for females.  The median age for malignant  tumors was 6 years 
younger than that for benign tumors. They showed marked female predominance with 
a female to male ratio of 1.6:1. The female to male ratio was 1.9:1 for malignant 
tumors  and 1:1.1 for benign tumors.  Palate  was  the most  common site  for  minor 
salivary gland tumors reporting 43 cases (53.8%), followed by 13 cases in  buccal 
mucosa (16.3%), 6 in upper lip (7.5%), 5 in retromolar fossa (6.2%), 5 in maxilla 
(6.2%), 4 in mandible (5%) and 4 cases in lower lip (4%).
Vargas  et  al  in  200237 retrospectively  studied  salivary  gland  tumors  in 
brazilian population for a period of 7 years and reported a mean age of 47.7 years for 
benign tumors and 48.8 years for malignant tumors.
Pandey et al in 20039 analyzed 42 cases of malignant minor salivary gland 
tumors for a period of 17 years and observed that the patient’s age ranged from 14 to 
76  years  with  a  mean  age  of  46.9  years. Their  study  showed  a  slight  male 
predominance with a male to female ratio of 1.4:1. Palate was the most common site 
accounting for 11 cases (26.1%), followed by 7 cases (16.6%) in pharynx, 5 cases 
(11.9%) in tongue, 4 cases (9.5%) in  buccal mucosa, 3 cases (7.1%) in retromolar 
trigone, 2 cases (4.7%) each in floor of the mouth and tonsil, 1case (2.3%) in lip and 
the site was not known in 6 cases (14.2%).
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Sajeevan et al in 200310 analyzed 30 cases of salivary gland lesions over a 
period of 9 years and observed that the age ranged from 20 to 29 years to above 60 
years. 50% of these tumors occurred in 30 to 39 years. They showed a marked female 
predominance with a male to female ratio of 2:1.
 Hyam et al in 200438 studied 30 cases of malignant minor salivary gland 
tumors over a period of 22 years and observed that the mean age was 62 years with a 
range of 22 to 86 years. They showed an equal frequency of malignant minor salivary 
gland  tumors  in  both  males  and  females  with  a  ratio  of  1:1.  Palate  was  most 
commonly involved with 18 cases (60%) followed by buccal mucosa and oropharynx.
Kasangaki et  al  in 200439 analyzed 142 cases of salivary gland tumors in 
Uganda population over a period of 12 years and observed that the mean age for 
salivary gland tumors in the Uganda population was 33.83± 18.83 with an age range 
of 1 to 80 years. The mean age of benign neoplasm was 26.74±16.0, while that of 
malignant neoplasm was 42.49±9.15. The peak incidence was in the third decade. The 
male to female ratio was 1:1.18 showing equal frequency in both genders. Site was 
unspecified in 67 cases (47.2%). Of the remaining cases, palate was most commonly 
involved with 34 cases (23.9%), followed by 20 cases (14.1%) in parotid gland, 12 
cases (8.5%) in floor of the mouth, 3 cases (2.1%) in lip, 2 cases (1.4%) in gingiva, 2 
cases (1.4%) in retro molar region and 2 cases (1.4%) in maxilla.
Nagarkar et al in 20042 conducted a retrospective study on 36 salivary gland 
tumors  over  a  period  of  4  years  and  observed  that  palate  was  most  commonly 
involved with 66.6% followed by 33.4% in buccal mucosa.
Vuhahula in 200440 conducted a clinicopathological study on salivary gland 
tumors in Uganda over a period of 10 years and showed that the age range was 0.5 to 
80 years, with a mean age of 38.1 years. The mean age of patients with benign tumors 
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was 33.5 years and those of malignant tumors were 43.1 years.  There was female 
predominance with a male to female ratio of 1:1.3. 
Lima et al in 200541 conducted an epidemiological survey on salivary gland 
tumors over a period of 19 years and observed that the mean age for benign tumors 
was 40.1 years and 54.8 years for malignant tumors. The peak incidence for benign 
tumors was in third decade and for malignant lesions, the peak incidence is in the 
seventh decade. They reported female predominance with a male to female ratio of 
1:1.6. The ratio for benign tumors was 1:1.67 and 1:1.64 for malignant 
Toida  et  al  in  200542 retrospectively  studied  82  cases  of  intraoral  minor 
salivary gland tumors over a period of 24 years and reported that the age ranged from 
10 to 90 years with a mean age of 51.4±18.1 years. The age range for benign tumors 
was 10 to 90 years with a mean of 49.4±18.4 years and the age range for malignant 
tumors was 14 to 83 years with a mean of 55.4±17.3 years. The peak incidence was 
between the fifth and the seventh decades. There was female predominance with a 
male  to  female  ratio  of  1:1.9.  Benign  tumors  showed  a  marked  predilection  for 
females whereas the malignant tumors showed a slight predilection for males. Palate 
was the most common site with 64 cases (78.1%), followed by 10 cases (15.62%) in 
buccal mucosa, 6 cases (9.38%) in upper lip and1 cases (1.56%) each in floor of the 
mouth and retromolar region.
Jaber et  al  in  200644 reviewed 75 cases  of  intraoral  minor  salivary gland 
tumors in Libyan population over a period of 23 years. They observed that the mean 
age at diagnosis of salivary gland tumors was 44.2 years with a range of 15 to 86 
years. The median age of patients with benign tumors was 44.1 years with a range of 
15 to 86 years and 44.3 years for malignant tumor with a range of 19 to 70 years. The 
peak occurrence was in the fifth decade for males and sixth decade for females. The 
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male to female ratio was 1:1.4. Palate was most commonly involved with 26 cases 
(34.6%) being reported, followed by 11 cases in cheek (14.6%), 8 in tongue (10.6%), 
9 in upper lip (12.0%), 2 in lower lip (2.6%), 7 in retromolar area (9.3%), 8 in floor of 
the mouth (10.6%), 2 in mandible (2.6%) and 2 cases in maxilla (2.6%). 
Buchner et  al  in  200745 conducted  a  retrospective  study on  380 cases  of 
intraoral minor salivary glands during a period of 20 years and reported  that palate 
was commonly involved with 206 cases (54.21%), followed by 64 cases (16.84) in 
upper lip, 54 cases (14.21%) in buccal mucosa, 20 cases (5.26%) in retromolar region, 
18 cases (4.74%) in lower lip, 13 cases (3.42%) in floor of mouth and 5 cases (1.31%) 
in tongue.
Pires et al in 200746 conducted a clinicopathological study on 546 cases of 
intraoral minor salivary gland tumors over a period of 14 years and found that the 
mean age of patients affected with minor salivary gland tumors was about 60 years, 
with 58 years for benign tumors and 62 years for malignant tumors. There was female 
predominance with a male to female ratio of 1:1.61. Palate was the most common site 
accounting for 181 cases (33.4%). This was followed by upper lip with 106 cases 
(19.6%), buccal mucosa with 98 cases (18.1%), vestibule with 39 cases (7.2%), lower 
lip with 38 cases (7%), alveolar ridge with 36 cases (6.6%), floor of the mouth with 
21 cases (3.9%) and 23 cases (4.2%) in other intraoral sites.
 Wang et  al  in  200747 conducted a  retrospective study on intraoral  minor 
salivary gland tumors in Chinese population over a period of 14 years and reported 
that the average age of patients for benign tumors was 40.7 years with an age range of 
3 to 82 years. The peak incidence was between third and fifth decade. In case of 
malignant tumors, the mean age was 49.4 years with a range of 14 to 85 years. The 
peak  incidence  was  between  fifth  and  seventh  decade. They  observed  an  equal 
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frequency, with a male to female ratio of 1:1.07. The male to female ratio was 1:1.1 
for  benign  tumors  and  1.2:1  for  malignant  tumors.  Palate  (67.4%)  was  most 
commonly involved,  followed by buccal mucosa (10.4%) and lips (7.1%). Benign 
tumors showed predilection for palate (77.4%) followed by lips and buccal mucosa 
(9.1%) each and other regions (4.4%). Malignant tumors also showed predilection for 
palate (58.9%), followed by buccal mucosa (11.6%), floor of mouth (9.1%), tongue 
(7.8%) and lips (5.3%). Their study revealed that the tumors of tongue, floor of the 
mouth, alveolar mucosa and retromolar area were predominantly malignant.
Copelli et al in 200848 reviewed 43 cases of malignant minor salivary gland 
tumors over a period of 9 years and observed that the age range for malignant minor 
salivary gland tumors was from 15 to 83 years with a mean age of 53.9 years. They 
observed an equal distribution in both sexes. Palate (53.5%) was the most common 
site followed by 9.3% each in floor of the mouth and retromolar area, 6.9% each in 
alveolar mucosa and tongue, 4.7% each in lip, cheek and mandible.
Jones et al in 200849 conducted a demographic study on 741 salivary gland 
tumors over a period of 31 years and observed that the age ranged from 14 to 95 years 
with  a  mean  age  of  57.7  years  for  benign  tumors.  Likewise,  the  age  range  for 
malignant tumors was 16 to 91 with a mean age of 56.6 years. They reported an 
overall female predominance, with a male to female ratio of 1:1.4 for benign tumors 
and 1:1.6 for malignant tumors. Palate was the most common site accounting for 227 
cases (49.8%), followed by 93 cases (20.4%) in upper lip, 55 cases (12.0%) in buccal 
mucosa, 21cases (4.6%) in maxillary gingiva, 14 cases (3.0%) in lower lip, 8 cases 
(1.8%) each in floor of mouth and retro molar area, 7 cases (1.5%) each in tongue, 
naso pharynx and fauces, 5 cases (1.1%) in mandibular gingiva, 3 cases (0.9%) in 
tuberosity, 1 case (0.2%) intra osseously in mandible and the site was unknown in 2 
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cases (0.4%).
Subhashraj et al in 200812 analyzed 684 cases of salivary gland tumors over a 
period of 16 years and found that the average age range for benign tumors was 41 to 
50 years with a mean age of 43 years. The average age range for malignant tumors 
was 51 to 60 years with a mean age of 56 years. The peak incidence was fifth decade 
for female patients and sixth decade for male patients. They showed an overall male 
predominance, with a male: female ratio of 1.04:1. The ratio was almost similar for 
both benign and malignant tumors. Palate was the commonest site reporting almost 
102 cases (68%), followed by buccal mucosa with 22 cases (15%), floor of the mouth 
with 14 cases (9%) and 12 cases in lips (8%).
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      MATERIALS AND METHODS
Clinical data were collected from the files of histopathology reporting register 
of  the Department  of  Oral  Pathology and Microbiology,  Tamil  Nadu Government 
Dental  College  and  Hospital  (under  the  Ministry  of  Health  and  Family  welfare, 
Government  of  Tamil  Nadu),  Chennai,  South  India  for  a  period  of  37  years 
[1971-2008]. A total of 12150 cases of oral and maxillofacial lesions were diagnosed 
during this period. Out of which 221 salivary gland tumors were retrieved (8 cases 
from a review of odontogenic tumors). Clinical information with respect to patient’s 
age,  sex,  anatomic location and histopathologic  diagnosis  were obtained  from the 
register. Hematoxylin and Eosin stained slides were available for most of the cases 
and were reviewed by two independent oral pathologists. Consensus was reached for 
so many cases. When necessary, four micron thickness sections were cut from tissue 
blocks  and  stained  with  Hematoxylin  and  Eosin  stain.  Special  stains  including 
periodic acid Schiff and mucicarmine stain were used in selected cases to aid in the 
diagnosis. Major salivary gland tumors accounted for 4 cases and were excluded from 
the study. On review, about 10 cases that  failed to meet the diagnostic criteria of 
salivary gland tumors were also excluded. Further, almost 19 cases were excluded 
from the study due to non-availability of slides and tissue blocks, three salivary gland 
tumors identified from the review of odontogenic tumors were also excluded for lack 
of consensus and due to the need for IHC studies to confirm the diagnosis. Tumors 
that recur post-operatively were considered as a single case. Salivary gland tumors 
were classified according to the criteria of the WHO working group on histologic 
classification of salivary gland tumors published in 200550 (Table 1).  
Procedure for Hematoxylin and Eosin staining  51  
• Sections are deparaffinized with xylene.
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• Hydration with descending grades of alcohol.
• The sections are drained and transferred to Hematoxylin, where they are 
left for 10 minutes.
• The slides are then drained and washed in running water until the sections 
are blue.
• The sections are dipped in acid alcohol where they are agitated for a few 
seconds and again washed in running water until blue again.
• The sections are counterstained with eosin for 30 seconds.
• The sections are washed in running water for 3-4 minutes, to differentiate 
the eosin.
• After draining, the sections are dehydrated in ascending grades of alcohol.
• The sections are cleared with xylol, where they are given two changes for 
30 seconds each.
• The sections being clear, the slides are dried and mounted with Distrene 80 
Dibutyl phthalate Xylol (DPX) under a coverslip.
RESULTS:
1. Nuclei:        Blue.
2. Cytoplasm:  Varying shades of pink.
PAS technique  51  
• Bring sections to water.
• Oxidize for 5-10 minutes in 1 per cent aqueous periodic acid.
• Wash in running water for 5 minutes and rinse in distilled water.
• Treat with Schiff reagent for 10-30 minutes.
• Transfer directly to first sulphite rinse for 1 minute.
• Transfer directly to the second sulphite rinse for 2 minutes.
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• Transfer directly to the third sulphite rinse for 2 minutes.
• Wash for 10 minutes in running water.
• Counterstain with Hematoxylin and tartrazine in cellosolve.
• Dehydrate, clean and mount in D.P.X or Canada balsam.
RESULTS:
1. P.A.S positive substances:   Bright red.
2. Nuclei:                                   Blue
3. Other tissue constituents:      Yellow
Mucicarmine technique  51  
Solution:
Carmine                          : 1 g
Aluminium hydroxide    : 1 g
50 per cent alcohol         : 100 ml
    These constituents are mixed by shaking and to them is added
Aluminium chloride      : 0.5 g
    Boil in water-bath for 2 ½ - 3 minutes. Cool, make up to original volume with 50 
per cent alcohol, and filter. The stock solution is stable for several months.
METHOD:
• Bring sections to water.
• Stain nuclei with haematoxylin.
• Differentiate in acid-alcohol and blue in tap-water.
• Stain for 30 minutes in the staining solution given above.




Mucin   : Red
Nuclei   : Blue
The stained and mounted slides for all cases were examined under the light 
microscope to confirm the previous histopathologic parameters.
Statistical analysis:
The mean and standard deviation was calculated, values were verified using 
chi square test and their significance was assessed by calculating the P value. The data 
were analyzed by the statistical package for the social sciences version 15.0 (SPSS). 
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Observations & Results
     General frequency
During a period of 37 years (1971 – 2008), a total of 12,150 oral biopsies were 
received  in  the  Department  of  Oral  Pathology  and  Microbiology,  Tamil  Nadu 
Government  Dental  College  and  Hospital,  Chennai,  India.  Of  these,  the  minor 
salivary gland tumors were 185 cases which accounted for 1.52% of all oral lesions.
Among these, 46 cases (24.9%) were benign tumors and 139 cases (75.1%) 
were malignant tumors. The malignant tumors were almost three times more common 
than the benign tumors in our study.  
Table 2 – General frequency of minor salivary gland tumors. 
Chart 1 – Frequency of minor salivary gland tumors.
Incidence of Minor salivary gland tumors over decades (1971 – 2008):
The incidence of intraoral minor salivary gland tumors were assessed in four 
decades from 1971 to 2008. Our study showed a steady increase in the frequency of 
minor salivary gland tumors over the decades. An almost similar incidence rate was 
observed from 1971 to 1980 and 1981 to 1990, following which there was an increase 
in the incidence rate from 1991 onwards. Our study also revealed a drastic increase in 
the  incidence  rate  from  2001  to  2008  showing  a  trend  towards  increase  in  the 
incidence rate of minor salivary gland tumors in the recent years.
Table 3 – Frequency of minor salivary gland tumors over 4 decades (1971-2008). 
Chart  2 –  Number  of  minor  salivary  gland  tumors  distributed  over  4  decades 
(1971-2008).
Chart 3 – Incidence of minor salivary gland tumors over 4 decades (1971-2008)
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  Age distribution
The age range of  patients  with minor  salivary gland tumors  in  the present 
study was 12 to 82 years, with a mean age of 46.11±13.92 years. The peak age of 
occurrence was in 5th and 6th decades. 
The age range for benign tumors was from 13 to 70 years, with a mean age of 
33.5±13.0 years and a peak age of occurrence in 4th and 5th decades. Likewise, the age 
range for malignant tumors was from 12 to 82 years, with a mean age of 41.3±13.0 
years. The peak age of occurrence for malignant tumors was in the 5th and 6th decade. 
`The  age  range  for  male  patients  was  from 13  to  80  years,  with  a  mean  age  of 
46.55±13.80 years and the age range for female patients was from 12 to 82 years, with 
a mean age of 46.11±14.07 years. The peak incidence of occurrence for both males 
and females was in the 5th and 6th decades of life. The malignant tumors also showed a 
slight predilection for older patients than the benign tumors. A statistically significant 
relationship was found between the age of the patients with benign and malignant 
tumors (P = 0.004).
Table 4 – Age distribution of minor salivary gland tumors in decades. 
Chart 4 – Age distribution (in decades) of minor salivary gland tumors.
Table 5 – Correlation of age (in decades) with gender. 
    Gender Distribution
There was a slight male predilection with 98 cases (53%) when compared to 
87 female patients (47%). The male to female ratio was about 1.12:1. The benign 
tumors  showed  a  slight  predilection  for  females,  whereas  the  malignant  tumors 
showed a marked predilection for males.
Table 6 – Gender distribution of minor salivary gland tumors 
Chart 5 – Gender distribution of minor salivary gland tumors.
48
Gender distribution over decades (1971-2008):
The gender distribution of minor salivary gland tumors was assessed over 4 
decades (1971-2008). Females showed a slight predominance over males in all the 
three  decades  (1970 – 2000)  with  a  transition  towards  male  predominance  in  the 
recent years (2000 – 2008).
Table  7 –  Gender  distribution  of  minor  salivary  gland  tumors  over  4  decades 
(1971-2008).
      Site Distribution
Palate was the most common site for minor salivary gland tumors with almost 
90 cases (48.6%) being reported in this location. This was followed by alveolus with 
27 cases (14.6%), floor of the mouth with 22 cases (11.9%), buccal mucosa with 14 
cases (7.6%), intraosseous (mandible) with 10 cases (5.4%), upper lip with 7 cases 
(3.8%), retromolar area with 6 cases (3.2%), maxillary antrum with 2 cases (1.1%), 
tongue and vestibule with 1 case (0.5%) each. The site was not specified in 5 cases 
(2.7%).
A statistically significant relationship was found between anatomic location 
and benign and malignant tumors (P = 0.001).
Table 8 – Site distribution of minor salivary gland tumors.
Chart 6 – Site distribution of minor salivary gland tumors.
       Individual Tumors
Among  185  minor  salivary  gland  tumors,  benign  tumors  were  46  cases 
(24.86%) while 139 cases (75.14%) were malignant tumors. Pleomorphic adenoma 
represented the majority of benign tumor with 40 cases which accounted for 87% of 
benign and 21.6% of MSGT. The other benign tumors reported in this study included 
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basal cell adenoma with 2 cases which accounted for 4.3% of benign and 1.1% of 
MSGT. A single case of cystadenoma, myoepithelioma, oncocytoma and sialadenoma 
papilliferum were observed which accounted for 2.2% of benign and 0.5% of MSGT 
each.
Among  the  malignant  tumors,  mucoepidermoid  carcinoma  represented  the 
most common malignant tumor with 63 cases. This represented 45.3% of malignant 
and 34.1% of MSGT. The adenoid cystic carcinoma was the second most common 
malignant tumor with 29 cases and accounted for 20.9% of malignant and 15.7% of 
MSGT. Our study observed polymorphous low-grade adenocarcinoma as the third 
most common malignant tumor with almost 18 cases (12.9% of malignant and 9.7% 
of MSGT) being reported. This was followed by 15 cases (10.8% of malignant and 
8.1% of overall tumors) of adenocarcinoma NOS, 8 cases (5.8% of malignant and 
4.3% of overall tumors) of basal cell adenocarcinoma, 2 cases (1.4% of malignant and 
1.1% of overall tumors) of clear cell carcinoma and a single case (0.7% of malignant 
and  0.5% of  overall  tumors)  of  sebaceous  carcinoma,  carcinoma  ex  pleomorphic 
adenoma, mucinous adenocarcinoma and salivary duct carcinoma each.
Table 9 – Frequency of individual minor salivary gland tumors. 
Chart 7 – Distribution of individual minor salivary gland tumors.
Benign tumors
Pleomorphic adenoma:
Pleomorphic adenoma was the most common benign tumor and represented 
87% of benign and 21.6% of minor salivary gland tumors. The age range observed in 
our  study was  from 13 to  70  years,  with  a  mean age  of  46.24±14.05.  The  peak 
incidence was in the fourth and fifth decades of life. The age range for males was 13 
50
to 60 years with a mean age of 46.62±13.86 years, whereas the age range for females 
was 19 to 70 years with a mean age of 46.40±14.09 years. There was a slight female 
predominance, with a male to female ratio of 1:1.2. Palate was the most common site 
with 27 cases (67.5%), followed by 5 cases in upper lip (12.5%) and 1 case (2.5%) 
each in alveolus, buccal mucosa, floor of the mouth, retromolar area and vestibule. 
The site was not specified in 3 cases (7.5%).
Other benign tumors:
The  other  benign  tumors  observed  in  our  study were  basal  cell  adenoma, 
cystadenoma, oncocytoma, myoepithelioma and sialadenoma papilliferum.
Two cases of basal cell adenoma was reported which accounted for 4.3% of 
benign and 1.1% of all tumors. One case was diagnosed in a 58 year old male in 
palate and the other case was observed in a 50 year old female in alveolus.
A single case of cystadenoma was reported in a 37 year old male patient in 
palate.  Similarly,  a  single  case of myoepithelioma was observed in a  65 year old 
female in the floor of the mouth. Oncocytoma was found in a 70 year old male patient 
in the palate and a rare case of sialadenoma papilliferum with epithelial dysplasia and 
carcinoma in situ was observed in a 40 year old male in floor of the mouth.
               
     Malignant tumors
Mucoepidermoid carcinoma:
Mucoepidermoid carcinoma was the most common malignant tumor with 63 
cases and accounted for 45.3% of malignant and 34.1% of MSGT. The age range of 
the patients was from 12 to 82 years, with a mean age of 46.31±14.08 years. The age 
range for males was 16 to 78 years, with a mean of 47.16±14.02 whereas the age 
range for females was 12 to 82 years, with a mean age of 46.20±14.16 years. The 
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peak  incidence  was  observed  in  fifth  and  sixth  decades.  This  tumor  showed  a 
predilection for males, with a male to female ratio of 1.25:1. Palate was the most 
common site with 32 cases (50.79%) followed by 11 cases (17.46%) in alveolus, 6 
cases (9.52%) each in floor of the mouth and mandible, 5 cases (7.93%) in buccal 
mucosa, 2 cases (3.17%) in retromolar area and 1 case (1.58%) in tongue.
Adenoid cystic carcinoma:
Adenoid  cystic  carcinoma  was  the  second  most  common  malignant 
tumor in our study with 29 cases and represented 20.9% of malignant and 15.7% of 
MSGT.  The  age  range  of  the  patients  was  21  to  62  years,  with  a  mean  age  of 
46.74±13.77.  The  age  range  for  males  was  23  to  61  years,  with  a  mean  age  of 
46.92±13.94 years whereas the age range for females was 21 to 62 years, with a mean 
of 46.79±13.80. The peak incidence was in the fifth and sixth decades. There was a 
slight male predominance with a male to female ratio of 1.2:1. The most common 
location was palate with 11 cases (37.93%) followed by 6 cases in floor of the mouth 
(20.68%), 4 cases (13.79%) in alveolus, 3 cases (10.34%) in buccal mucosa, 2 cases 
(6.89%) in maxillary antrum and 1 case (3.4%) each in retromolar area and mandible. 
The site was not specified in 1 case (3.4%).
Polymorphous low-grade adenocarcinoma:
Polymorphous low-grade adenocarcinoma was the third most common 
malignant tumor in our study with 18 cases which represented 12.9% of malignant 
and  9.7%  of  MSGT.  The  age  range  was  25  to  80  years,  with  a  mean  age  of 
47.03±14.11 years. The age range for male patients was 45 to 80 years, with a mean 
age of 54.60±13.80 whereas the age range for female patients was from 25 to 65 
years, with a mean of 47.36±14.25 years. The peak incidence occurred in the fifth 
decade. There was a marked female predilection with a male to female ratio of 1:2. 
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Palate was the most common location accounted for 8 cases (44.44%) which was 
followed by 3 cases (16.66%) each in buccal mucosa and mandible, 2 cases (11.11%) 
in upper lip and 1 case (5.55%) each in alveolus and floor of the mouth.
Adenocarcinoma NOS:
Fifteen  cases  were  diagnosed  as  adenocarcinoma  not  otherwise 
specified which accounted for 10.8% of malignant and 8.1% of MSGT. The age range 
of the patients was 25 to 75 years, with a mean age of 46.55±13.77 years. The age 
range for male patients was 25 to 66 years, with a mean age of 45.93±13.67 years 
whereas the age range for female patients was from 30 to 75 years, with a mean age of 
46.70±13.85  years.  The  peak  incidence  was  in  the  sixth decade.  There  was male 
preponderance with a male to female ratio of 2:1. Palate and alveolus was the most 
common site with 5 cases (33.33%) each followed by 4 cases in floor of the mouth 
(26.66%). The site was not specified in 1case (6.66%).
Basal cell adenocarcinoma:
Basal cell adenocarcinoma accounted for 5.8% of malignant and 4.3% 
of MSGT with 8 cases. The age range of the patients was 30 to 75 years, with a mean 
age of 47.20±14.16 years. The mean age for males was from 53 to 75 years, with a 
mean age of 63.4±14.08 whereas the age range for female patients was from 30 to 60 
years, with a mean age of 47.20±14.16 years. Palate was the most common site with 4 
cases (50%) followed by 2 cases (25%) in floor of the mouth and 1 case (12.5%) each 
in alveolus and buccal mucosa.
Other malignant tumors:
Two cases were diagnosed as clear cell carcinoma. One case occurred in 
a 40 year old male patient in alveolus and the other was reported in the retromolar 
area of a 65 year old male patient.
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The  other  malignant  tumors  included  a  single  case  of  sebaceous 
carcinoma in a 58 year old male patient in buccal mucosa; carcinoma ex pleomorphic 
adenoma in a 45 year old female in alveolus; mucinous adenocarcinoma in a 45 year 
old female in retromolar area and salivary duct carcinoma in a 26 year old male in 
alveolus were reported.
Table 10 – Age distribution (in decades) of individual minor salivary gland tumors.
Table 11 – Sex distribution of individual minor salivary gland tumors.
Table 12 – Site distribution of individual minor salivary gland tumors. 
Chart 8 – Gender distribution of individual minor salivary gland tumors.
54
    Discussion
Comparison of actual variation of the relative frequency of MSGT is difficult 
to  establish.  This  is  because  of  the  difference  in  the  assessment  of  the  relative 
frequency  of  MSGT where  some  have  adopted  to  establish  it  by  calculating  the 
overall  prevalence of MSGT with respect to other head and neck malignancies or 
tumors, while others have established the relative frequency of MSGT among the total 
biopsies encountered during the study period. The latter method is further complicated 
by the fact that some institutional analysis were reported from the oral surgery unit, 
which  did  not  state  whether  their  review  included  re-analysis  of  the  original 
histological diagnosis. These differences will lead to variations in the assessment of 
the actual rate of the relative frequency of individual MSGT. 
When reports from the tertiary referral units are compared with those from the 
institution,  the relative percentage of malignant tumors is bound to be high in the 
tertiary  referral  centre,  because  of  the  more  number  of  invasive  cancer  cases 
encountered in such reference centers.22 On the other hand, the institutional based 
assessment of relative frequency will not only have lesser number of salivary gland 
tumors 1, 28, 31, 33, 36, 42, 44 when compared with the total number of biopsies but also lesser 
percentage of malignant tumors when compared to the overall salivary gland tumors. 
1,   12,  17,   24-30,   32,  34,  42-46,  49 Another  problem is  the  extrapolation  of  the  data  of  an 
institutional study to the population density in a given geographic or regional location, 
where the population figures are not static over a long period compared to the study 
period that may range from one or more decades involved in an institutional study.
The results of the present study reports 185 (out of a total of 12150 biopsy 
samples)  minor  salivary  gland  tumors  over  a  period  of  37  years.   The  relative 
frequency of minor salivary gland tumors was 1.52%. Benign and malignant tumors 
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constituted 24.9% and 75.1% respectively (see. Table 2).
Review of the literature revealed that the relative frequency of MSGT in the 
institutional studies ranged from 0.3% to 0.7%.1, 27, 35, 45, 46 Spiro et al,22 have reported a 
rate  of  1.5% but  this  also  included other  malignant  tumors.  Minor  salivary gland 
tumors  in our study represented 1.52% of all  oral  biopsies.  This incidence rate  is 
higher compared to the range stated.
The prevalence of malignant minor salivary gland tumors were found to be in 
the range of 53.9% to 88.2% 22, 33, 35, 36, 44, 47 from studies that showed a higher incidence 
of  malignant  tumors  than  benign  tumors  in  their  analysis  of  MSGT.   The  higher 
incidence of malignant tumors found in this study is consistent with these results. But 
our figure of 75.1% is comparatively higher when compared to other reported studies 
that showed predominance of benign over the malignant tumors, a range of 28% to 
46.8% of malignant tumors.1, 12,  17,  24-30,  32,  34, 42, 43, 45, 46, 49 These low and high figures 
were  found  both  within  the  institutional  based  studies  and  across  the  geographic 
location. Toida et al42 and Wang et al47 have found that 33% to 53.9% of the MSGT 
were malignant tumors in their study. Though our geographic location is closer to 
Japan and China (Toida et al & Wang et al), the high incidence of malignant tumors 
found in this study (75.1%) corresponds to the values obtained by Jansisyanont et al 
(76.3%), in United States of America.36 This indicates not only regional variation but 
also  differences  in  the  ethnicity within a  geographic  location  as  evident  from the 
figures in Table 13. Furthermore, as evident from studies conducted within the Indian 
population, also reflects variations in the incidence of benign and malignant tumors – 
Table 14.
The relative prevalence of malignant salivary gland tumors (both minor and 
major) was 0.46% to 0.54% according to the annual report of MMTR for the year 
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2001-2003  and  2003-2005,  respectively.7,  8 This  indicates  that  the  incidence  of 
salivary gland cancers shows an increase during the respective periods in the same 
population group in which the present analysis was conducted. Our study revealed, 
from 1971 to 2008, a steady increase in the incidence rate of overall MSGT with an 
upward trend in the incidence of minor salivary gland tumors, especially in the last 
decade (see. Table 3). This observation is interesting in view of the notable decrease 
in the incidence of oral cancers as reported by the MMTR,8 while the percentage of 
malignant tumors (MSGT) were found to be higher in the present institutional based 
study.
This study also identifies the age of patients  to range from  12 to 82 years 
(mean 46.11±13.92 years) with a peak incidence in the fifth and sixth decades of life 
for both males and females. Like most other reported series,1, 17, 22, 26, 28, 30, 34, 35, 42, 44, 46, 47 
our study also reveals that the malignant tumors showed a slight predilection for older 
patients (see. Table 4 & 5).  In contrast, only one report showed the occurrence of 
malignant tumors at a relatively younger age.36 Moreover, there was a statistically 
significant correlation of age with both benign and malignant tumors, similar to other 
reported series.24,  26,  30,  31 
In the present study, the prevalence of MSGT was found more in males (53%) 
than in females (47%) with a ratio of 1.12:1 (see.Table 6).  This observation is in 
accordance with Takayashi et al30 and Potdar et al,14 but in contrast to others.1, 17, 22, 28, 
29-36,  42,  44,  45,  47   When gender  distribution  was  assessed  over  decades  (1971-2008), 
female predominance was observed. Nevertheless, there was a sudden shift towards 
male  predilection  during  the  last  decade  (2001-2008  –  see.  Table  7).  Overall,  in 
agreement with other studies, 1, 35, 47 malignant tumors tend to occur more frequently in 
males in this study.  The MMTR also reports increase in the incidence of oral cancers 
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in males during this period compared to previous decades.8
As in the present study, review of literature revealed the palate being the most 
commonly affected site.1,  9,  11-14,  17,  22,  24-36,  42-49 In the present study,  48.6% of cases 
occurred in the palate. This figure although comparable with some studies, 22,  27, 44, 46 
was found to be lower with most other studies. 1, 16, 26, 28, 30, 34-37, 42, 45, 47 On the other hand, 
the palate was the single most frequent site for benign tumors than for malignant 
tumors, similar to most other studies. 1, 22, 24, 27, 28, 31, 34, 35  According to MMTR data,8 the 
tongue and buccal mucosa are the most frequently involved site for cancers of the oral 
cavity.
The  anatomical  distribution  of  minor  salivary  gland  tumors  found  in  the 
present  study  differs  from  other  reported  studies.  Unlike  in  most  other  reported 
series,12, 16, 26, 28, 34, 36, 42,  44, 47 where the buccal mucosa was identified as the second most 
common site, the present study found the alveolus (14.6%) to be the second most 
common site.  The  present  study also  identifies  positive  correlation  for  malignant 
tumors occurring at  specific sites,  similar  to the observation made by Eveson and 
Cawson26  and  Potdar  et  al.14 Tumors  in  certain  intra-oral  sites  such  as  tongue, 
maxillary antrum and mandible were invariably found to be malignant (see. Table 8). 
This  shows  a  statistically  significant  correlation  between  the  site  and  malignant 
salivary gland tumors.
Another  notable  finding  was  the  incidence  (5.4%)  of  intraosseous  MSGT 
(mandible) found in this study compared to a range of 0.2% to 2.6%.1, 29, 30, 33, 44, 49   The 
higher incidence found in our study is similar to that reported by Jansisyanont et al.36 
Our  review  (10  cases)  initially  identified  7  cases  of  intraosseous  salivary  gland 
tumors. Another 3 cases (MEC, ACC and PLGA) was retrieved from the review of 
odontogenic  tumors,  which  was  either  reported  as  malignant  or  plexiform 
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ameloblastoma. Overall, there were 6 cases of MEC, 3 of PLGA and a single case of 
ACC.  The frequency of MEC and site of predilection of intraosseous tumors is in 
agreement with Li et al.52 
Pleomorphic adenoma was the most common benign MSGT in our study that 
accounted for 21.6% of MSGT. This is consistent with the worldwide prevalence rate 
ranging from 11.6 to 66.6 % of MSGT.1,  2,  12,  17-19,  21-37,  42-47,  49 But interestingly, our 
figure  of  21.6%  although  similar  to  that  reported  by  Jansisyanont  et  al,36 is 
comparatively lower with other studies from India, as well as from other geographic 
locations.1,2, 9-15, 17, 21, 26-35, 42-47, 49 
Like most reported series,26,  28,  30,  36,  42,  43,  46,  47 our study also identifies palate 
(67.5%) as the most commonly involved site for PA  followed by upper lip (12.5%). 
In  PA,  female  predominance  was  observed  in  the  ratio  of  1:1.2,  which  is  in 
accordance with the previous reports ranging from 1:1.1 to 1:2.5.1, 22, 24, 26, 27, 29-31, 42, 43, 
45-47, 49
Our study identified basal cell adenoma as the second most common benign 
MSGT that accounted for 4.3% of benign and 1.1% of MSGT. Although our data is 
similar to that reported by Takahashi et al,30 Lopes et al35   and Subhashraj et al,12 is 
substantially lower compared to a range of 1.25 – 7.7% reported in other studies.1, 35, 36, 
44, 45, 49  
The absence of CA in the present study is notable, especially in view of its 
reported prevalence  (1.25% to 11.74%) in  minor  salivary glands  in  the American 
population.17, 22, 25, 27, 29, 36, 43, 45, 46 Although others might consider it due to differences in 
the diagnostic interpretations,45 it might be a distinct feature in Asian population as 
almost all studies from this region have found no CA in their analysis, 2, 9-15, 30, 42 , 47 and 
in fact  one case of ACC was reported as CA before this review. Our review also 
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showed two ACC that had acceptable focus of BCA and CA, respectively. But in 
view of the malignant component being ACC, it was diagnosed as such.
Myoepithelioma accounted for 5.7% of all  benign MSGT according to  the 
report  in  the  WHO  classification.50 In  the  present  study,  the  proportion  of 
myoepithelioma was 2.2% of benign and 0.5% of MSGT which is in accordance with 
Pires et al.46 However, this is substantially lower compared to other studies reporting 
an  incidence rate  ranging  from 1.3% to 8.8%. 17,  45,  47,  49 Further,  a  single  case  of 
oncocytoma was found in our study which accounted for 0.5% of MSGT, similar to 
that observed by Yih et al,43  Jones et al. 49 and subhashraj et al.12
Sialadenoma papilliferum is a rare benign tumor of salivary gland origin and 
was ﬁrst described by Abrams and Finck in 1969.53 The present study also observes a 
case of sialadenoma papilliferum but with epithelial dysplasia and carcinoma in situ in 
the exophytic component. This lesion was found in the floor of the mouth.54 
The relative frequency of malignant MSGT varies around the world; studies 
from American population show that MEC is the most common tumor,17, 25, 27, 29, 36, 43, 45, 
46 while most studies from European and Asian countries  have observed ACC as the 
most common malignant tumor.2, 11-15, 26, 30,  33, 42, 47   Most studies from India have also 
observed ACC to be the most common malignant tumor.2, 11-15, 55 Our study observed 
mucoepidermoid  carcinoma  as  the  most  common  malignant  MSGT  followed  by 
adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. A similar 
pattern of frequency was also observed by others.43, 46 
MEC in the present study comprised of 45.3% of malignant and 34.1% of all 
MSGT and was found in the palate more often than any other intra oral site. These 
observations is in accordance with other studies.1, 9, 17, 21, 22, 24, 25, 27-29, 34-36,  38, 45, 46, 49  Of the 
malignant  MSGT  found  in  this  study  ,  MEC  was  also  the  most  common 
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adenocarcinoma to involve the palate. 
With regard to involvement in children (1.4%), MEC was the only malignant 
tumor  that  affected  children  below  16  years  of  age.  In  general,  the  incidence  of 
intraosseous  (mandible)  MEC  (9.52%)  was  found  to  be  higher  than  others,28,  43 
although a higher incidence rate (12.1%) was found by Jansisyanont et al.36
Adenoid cystic carcinoma was the second most common malignant MSGT in 
our study and accounted for 20.9% of malignant and 15.7% of all MSGT. This is 
consistent with other reported series.1,  17,  25,  27,   28,  34,   35,  43,  44,  46,  49 Like most reported 
studies,1, 9, 12, 17, 21, 22, 24-36, 38, 42-49  the most common site of involvement of this tumor is 
the palate (50.79%), while  the maxillary sinus accounted for only 6.89% (2/29 cases) 
of this tumor as against a higher prevalence of this tumor in  this  location.22,  50,  56 
Similarly, central adenoid cystic carcinoma was found to be relatively common,57 but 
only a single case (mandible) was identified in this series.  
PLGA appears to show greater affinity for minor salivary glands as is evident 
from the increasing recognition of this entity,29, 31 since its identification by Evans and 
Batsakis in 1983.58 The WHO classification also reports PLGA as the second most 
common malignant tumor of minor salivary gland origin.50 The present study observes 
PLGA  to  be  the  third  most  common  malignant  tumor  accounting  for  12.9%  of 
malignant MSGT. PLGA was found to be the most common malignant tumor in an 
African  series,31 while  it  was  the  second most  common malignant  tumor  in  some 
America series. 29, 36, 45 The reported variation in the prevalence of this entity might be 
related to differences in interpretations. Prior to 1983, this tumor was interpreted as 
other  salivary  gland  tumors,  most  commonly  as  adenoid  cystic  carcinoma  or 
pleomorphic adenoma. Of the 18 cases of PLGA, in the study by Yih et al,43 8 were 
interpreted as pleomorphic adenomas and 1 as adenoid cystic carcinoma before 1983. 
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Our review (18 cases) also revealed that PLGA was interpreted as other lesions, two 
as  PA  and  one  was  diagnosed  as  plexiform  ameloblastoma,  before  1983,  and 
thereafter, 6 cases were interpreted as MEC, ACC and adenocarcinoma NOS. This 
indicates that PLGA is not only difficult for general pathologist to interpret,59 as it is 
not  frequent  in  major  salivary  glands  but  also  for  specialist  pathologist.  This  is 
perhaps  due  to  overlapping  histomorphological  features  with  other  salivary gland 
tumors.59 The 3 cases of PLGA that was interpreted as MEC, before this review, was 
possibly due to the abundance of mucous cells in an otherwise PLGA. As reported in 
other studies,29,  31,  36,  38,  43-47,  49,  59 the present study also found higher predilection for 
both the site and gender. Over 44% of PLGA was found in the palate, and a 2:1 ratio 
of female predominance was observed. Furthermore, our study also found 3 cases (1 
in male & 2 in females) of intraosseous PLGA, which is an uncommon location for 
this tumor.60 
The  diverse  histological  features  of  salivary  gland  neoplasms  present 
difficulties in the diagnosis of a small number of lesions. Such tumors are categorized 
as adenocarcinoma NOS, which are a histologically heterogeous group of tumors that 
could not be classified into a well-defined specific category.50 This tumor accounts for 
8.1% (15 cases) of MSGT in our study, which is higher than the range of 0.8 to 7.4% 
reported in other studies.1, 17, 24, 27, 28, 30, 34-36, 38, 42, 43-49 Most studies from India also report 
higher values (9 to 26%) of this non-specific entity.9,11- 14
On review of the 22 cases of adenocarcinomas NOS reported in the biopsy 
register, re-classification yielded 3 cases of basal cell adenocarcinoma and one each 
of  mucinous  adenocarcinoma,  PLGA,  MEC  and  ACC.  The  palate  (33.3%)  and 
alveolus  (33.3%)  are  the  most  frequently  involved  sites,  this  observation  is  in 
accordance with Wang et al.47 Males are the predominantly affected gender groups in 
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most studies, 26, 28, 30, 42, 46, 47 as does the present study. 
Basal  cell  adenocarcinoma occur  mostly in  the parotid  gland and they are 
considered rare in minor salivary glands.50 Review of the literature revealed only 21 
reported cases of basal cell adenocarcinoma of minor salivary glands.61, 62 Our study 
identified 8 cases which accounted for 5.8% of malignant and 4.3% of MSGT when 
compared to a range of 0.2% to 1.2% reported by other large series. 42, 45, 49  
The rest of the malignant tumors together comprised only 3.1% of the MSGT 
to draw any meaningful comparison with other reported series. (see Table 9,10,11,12)
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 SUMMARY AND CONCLUSION
Our study reported 185 minor salivary gland tumors over a period of 37 years, 
showing a predominance of malignant tumors over benign tumors. The incidence rate 
was 1.52% with a steady increase over the decades (1971 to 2008). These tumors 
were  distributed  over  a  wide  age  range,  with  a  peak  incidence  in  fifth  and sixth 
decades. Males were most commonly affected compared to females. Almost one half 
of these tumors occurred in palate and the remaining tumors were identified in other 
intraoral  sites.  The intraosseous tumors observed in our study included 6 MEC, 3 
PLGA and 1 ACC. A statistically significant correlation was observed between age 
and anatomic location with benign and malignant tumors. 
Pleomorphic  adenoma  was  the  most  common  benign  tumor,  while  the  most 
common  malignant  tumor  was  mucoepidermoid  carcinoma  followed  by  adenoid 
cystic carcinoma and polymorphous low-grade carcinoma. Unlike in most other Asian 
studies,  our  study  identified  mucoepidermoid  carcinoma  as  the  most  common 
malignant tumor. A higher incidence of basal cell adenocarcinoma was also observed.
In conclusion, our study shows a higher incidence of minor salivary gland 
tumors compared to other studies with an incidence rate of 1.52%. Of these, 75% 
were malignant and the rest were benign tumors. The frequency of malignant tumors 
is significant in the context of the gradual trend towards decline in the incidence of 
oral cancers in Chennai. Further, a trend towards male predilection was observed in 
the recent times akin to the increasing incidence of oral cancers in males in this city. 
The frequency and distribution of MSGT in the present study shows both regional and 
geographic variations.  Further  epidemiological  studies  from India  and other  Asian 
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